IN8BIO, Inc.
INAB· Nasdaq
INABIN8BIO, Inc.
Filed May 7, 2026 · 10-Q · 37 days after period end · 0001193125-26-212135
| Metric | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 |
|---|---|---|---|---|
| Net Income | -$5.09M | -$5.55M | -$8.56M | -$7.53M |
| EPS Diluted | -$0.26 | -$2.16 | -$0.20 | -$0.30 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
IN8BIO, Inc. · CIK 1740279 · Engraved from SEC EDGAR
ended Mar 31, 2026 · filed May 7, 2026 · 37 d after period end
